Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Understanding what to expect upfront helps you navigate any discomfort and know when a conversation with your care team makes sense
Trial designs differ
We suggest PWS patients and their families talk to experts
PMID: 25494545): Association of Afamelanotide With Improved Outcomes in Patients With Erythropoietic Protoporphyria in Clinical Practice , published in JAMA Dermatology (Wensink D et al., 2020
Anti-doping considerations Retatrutide is not currently on WADA or USADA prohibited substance lists as it is still in clinical development
Many patients find direct payment more affordable than high-deductible insurance claims
US$ 22.07
US$ 23.79
US$ 24.44
